Sulfamethoxazole and Trimethoprim Tablets, USP | Sulfamethoxazole and Trimethoprim

20:20 EDT 22nd September 2014 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.
IMAGE sulfatrime-str1.jpgIMAGE sulfatrime-str2.jpg
Weight
Dose–every 12 hours
lb
kg
Tablets
22
44
66
88
10
20
30
40

1

2 or 1 DS tablet
Creatinine Clearance (mL/min)
Recommended Dosage Regimen
Above 30
15–30
Below 15
Usual standard regimen
½ the usual regimen
Use not recommended

For the lower limit dose (75 mg/kg sulfamethoxazole and 15 mg/kg trimethoprim per 24 hours) administer 75% of the dose in the above table.

Weight
Dose–every 6 hours
lb
kg
Tablets
18
35
53
70
88
106
141
176
8
16
24
32
40
48
64
80

1

2 or 1 DS tablet

3 or 1½  DS tablets
4 or 2 DS tablets
5 or 2½ DS tablets
Body Surface Area
Dose–every 12 hours
(m2)
Tablets
0.26
0.53
1.06

½
1
Bottles of 30
NDC 54868-4711-0
Bottles of 10
NDC 54868-0021-6
Bottles of 14
NDC 54868-0021-2
Bottles of 15
NDC 54868-0021-5
Bottles of 20
NDC 54868-0021-1
Bottles of 30
NDC 54868-0021-7
Bottles of 60
NDC 54868-0021-4
Bottles of 100
NDC 54868-0021-0
Bottles of 120
NDC 54868-0021-3

Relabeling and Repackaging by: Physicians Total Care, Inc.Tulsa, OK      74146

IMAGE 4711.jpgIMAGE 0021.jpg

Manufacturer

Physicians Total Care, Inc.

Active Ingredients

Source

Drugs and Medications [129 Associated Drugs and Medications listed on BioPortfolio]

Sulfamethoxazole and trimethoprim [Teva Parenteral Medicines, Inc]

Sulfamethoxazole and Trimethoprim Injection, USP

Sulfamethoxazole and trimethoprim [Aurobindo Pharma Limited]

Sulfamethoxazole and Trimethoprim Oral Suspension, USP

Sulfamethoxazole and trimethoprim [Aurobindo Pharma Limited]

Sulfamethoxazole and Trimethoprim Tablets, USP

Sulfamethoxazole and trimethoprim oral suspension usp form no. 1284/1285 rev. 3/06 vc2785 [Actavis Mid Atlantic LLC]

SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION USP FORM NO. 1284/1285 Rev. 3/06 VC2785

Septra [Monarch Pharmaceuticals, Inc.]

SEPTRA Tablets SEPTRA DS (Double Strength) Tablets (trimethoprim and sulfamethoxazole)

Clinical Trials [63 Associated Clinical Trials listed on BioPortfolio]

A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency Syndrome

The primary objective of the study is to evaluate the effectiveness of l-leucovorin in preventing toxicity from high dose trimethoprim / sulfamethoxazole (TMP / SMX) used as a therapy for ...

A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS

To evaluate the effectiveness of two oral treatments for mild to moderate Pneumocystis carinii pneumonia (PCP): dapsone/trimethoprim or clindamycin/primaquine as compared to a standard tr...

Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

To compare the safety and effectiveness of an investigational drug therapy (trimetrexate plus leucovorin calcium) with that of conventional therapy (sulfamethoxazole-trimethoprim) in the t...

Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue Infections

Background: In many communities, skin and soft tissue infections (SSTI) with MRSA have become more prevalent than infections with β-lactam susceptible bacteria. This has necessitated alt...

A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients

To compare the safety and efficacy of two dosage regimens (daily and thrice-weekly) of sulfamethoxazole/trimethoprim (SMX/TMP; TMS) in the prevention of Pneumocystis carinii pneumonia (PCP...

PubMed Articles [92 Associated PubMed Articles listed on BioPortfolio]

Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe.

Co-trimoxazole (trimethoprim/sulfamethoxazole) is clinically valuable in treating skin and soft tissue infections (SSTIs) caused by community-associated methicillin-resistant Staphylococcus aureus (MR...

Prescriptions for a Toxic Combination: Use of Methotrexate Plus Trimethoprim-Sulfamethoxazole in the United States.

To determine the frequency of using the potentially toxic combination of methotrexate and trimethoprim-sulfamethoxazole (TMP-SMX) in outpatient practice in the United States.

Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of toxoplasma gondii retinochoroiditis: randomized controlled clinical trial.

To compare the effects of trimethoprim-sulfamethoxazole versus placebo in reducing the risk of recurrences of toxoplasma gondii retinochoroiditis.

Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome.

We present a case of a 7-year-old boy who had cholestasis after trimethoprim-sulfamethoxazole combination therapy. Liver biopsy was performed 36 days after the onset of jaundice because of no evidence...

Hepatotoxicity Induced by Trimethoprim-Sulfamethoxazole in a Child with Cystic Fibrosis.

Patients with cystic fibrosis (CF) have chronic and progressive lung infections with various bacterial organisms that require treatment with oral and intravenous antibiotics on a regular basis. Trimet...

Search BioPortfolio:
Loading
Advertisement
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record